Gerrard Schmid

CIK 1732384 · View on SEC EDGAR ↗

Insider

First SEC filing: Feb. 8, 2022 · Latest: Feb. 8, 2022

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 22 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

22 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
March 16, 2021 DBD S 9,412 $17.11 $161,039 564,336 Direct -1.64% Disposed 297.9% (price as of 2026-08-21)
March 16, 2021 DBD S 53,636 $16.39 $879,094 573,748 Direct -8.55% Disposed 315.4% (price as of 2026-08-21)
March 16, 2021 DBD S 9,412 $17.11 $161,039 564,336 Direct -1.64% Disposed 297.9% (price as of 2026-08-21)
March 16, 2021 DBD S 53,636 $16.39 $879,094 573,748 Direct -8.55% Disposed 315.4% (price as of 2026-08-21)
March 15, 2021 DBD S 39,449 $17.15 $676,550 627,384 Direct -5.92% Disposed 297.0% (price as of 2026-08-21)
March 15, 2021 DBD S 39,449 $17.15 $676,550 627,384 Direct -5.92% Disposed 297.0% (price as of 2026-08-21)
March 6, 2020 DBD P 10,000 $5.69 $56,900 578,856 Direct +1.76% Acquired 1096.5% (price as of 2026-08-21)
Oct. 31, 2019 DBD P 28,000 $6.94 $194,320 518,070 Direct +5.71% Acquired 881.0% (price as of 2026-08-21)
March 4, 2019 DBD P 22,222 $8.80 $195,554 490,070 Direct +4.75% Acquired 673.6% (price as of 2026-08-21)
May 8, 2018 DBD P 10,000 $11.85 $118,500 10,000 Indirect Acquired 474.5% (price as of 2026-08-21)
May 4, 2018 DBD P 8,300 $11.80 $97,940 117,245 Direct +7.62% Acquired 476.9% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Jan. 30, 2020 DBD Non-Qualified Stock Option [F4] Common Shares (253,907) Jan. 30, 2030 253,907 Acquired
Jan. 30, 2020 DBD Non-Qualified Stock Option [F4] Common Shares (253,907) $11.96 Jan. 30, 2030 253,907 Acquired
April 25, 2019 DBD Performance Share Units Common Shares (56,059) April 25, 2022 56,059 Acquired
April 25, 2019 DBD Non-Qualified Stock Option [F3] Common Shares (34,678) $13.98 April 25, 2029 34,678 Acquired
Jan. 29, 2019 DBD Non-Qualified Stock Option [F4] Common Shares (676,814) $4.49 Jan. 29, 2029 676,814 Acquired
Feb. 21, 2018 DBD Non-Qualified Stock Option [F3] Common Shares (192,049) $15.35 Feb. 20, 2028 192,049 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

DBD

CEO
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2022 $4,072,158 $4,291,389
2021 $3,063,679 $51,643 $26,169,529
2020 $1,133,160 $55,637 $5,312,150

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.